SEI Investments
LFCR icon

SEI Investments’s Lifecore Biomedical LFCR Stock Holding History

SEI Investments’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.5K Buy
+17,423
New +$87.8K ﹤0.01% 3197
2018
Q3 		– Sell
-20
Closed – – 3020
2018
Q2 		$0 Buy
+20
New +$278 ﹤0.01% 3718
2015
Q4 		– Sell
-25,714
Closed -$300K – 2615
2015
Q3 		$300K Buy
+25,714
New +$341K ﹤0.01% 1479

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

SEI Investments's LFCR Position: Q2 2026 in Review

SEI Investments opened a new position in Lifecore Biomedical (LFCR) in Q2 2026: 17,423 shares worth $91.5K. The stake represents ﹤0.01% of the portfolio and ranks #3197 among its holdings. This is a return to the name: SEI Investments previously reported a position in LFCR as recently as Q2 2018.

SEI Investments first reported a position in LFCR in Q3 2015 and has held it in 3 quarters since. The position peaked at $300K in Q3 2015. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • SEI Investments held 17,423 shares of Lifecore Biomedical worth $91.5K as of Q2 2026.
  • Lifecore Biomedical was a new SEI Investments position in Q2 2026.
  • Lifecore Biomedical made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3197 holding.
  • SEI Investments first reported a position in Lifecore Biomedical in Q3 2015 and has held it in 3 quarters since.
  • SEI Investments's Lifecore Biomedical position peaked at $300K in Q3 2015.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.